Novartis Pharmaceuticals Corporation v. Dr. Reddy's Laboratories Inc. et al > Summary
Court Case Number 1:22-cv-00498
Filing Date Apr 19, 2022
Termination Date Apr 26, 2023
Court Delaware District Court
Status Judgment - Judgment on Consent
JudgesRichard G. Andrews
Plaintiff
Defendant
Plaintiff Attorneys
6Novartis
Attorney Name: Alexandra M. Joyce
McCarter & English
Novartis
Attorney Name: Nicholas N. Kallas
Venable
Novartis
Attorney Name: Christopher E. Loh
Venable
Novartis
Attorney Name: Christina A. Schwarz
Venable
Novartis
Attorney Name: Daniel M. Silver
McCarter & English
Novartis
Attorney Name: Jared L. Stringham
Venable
Defendant Attorneys
4Dr. Reddy's Laboratories
Attorney Name: Christopher D. Jones
Perkins Coie
Dr. Reddy's Laboratories
Attorney Name: Stamatios Stamoulis
Stamoulis & Weinblatt
Dr. Reddy's Laboratories
Attorney Name: Bryan D. Beel
Perkins Coie
Dr. Reddy's Laboratories
Attorney Name: Autumn N. Nero
Perkins Coie
Counter Defendant
3Novartis
Attorney Name: Alexandra M. Joyce
McCarter & English
Novartis
Attorney Name: Christopher E. Loh
Venable
Novartis
Attorney Name: Daniel M. Silver
McCarter & English
Counter Claimant
Cause
35:271 Patent Infringement
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 11058667 | Sacubitril-valsartan dosage regimen for treating heart failure | Jul 13, 2021 |
